In search of the optimal platform for Post-Allogeneic SCT immunotherapy in relapsed multiple myeloma: a systematic review

Allogeneic stem cell transplantation (allo-SCT) has the potential to induce sustained remissions in patients with multiple myeloma (MM). Currently, allo-SCT is primarily performed in high-risk MM patients, most often in the setting of early relapse after first-line therapy with autologous SCT. Howev...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Bone marrow transplantation (Basingstoke) 2017-09, Vol.52 (9), p.1233-1240
Hauptverfasser:	Oostvogels, R, Uniken Venema, S M, de Witte, M, Raymakers, R, Kuball, J, Kröger, N, Minnema, M C
Format:	Artikel
Sprache:	eng
Schlagworte:	692/700/565/2319 692/700/565/251 Autografts Bone marrow Bortezomib Care and treatment CD34 antigen Cell Biology Clinical trials Depletion Dosage and administration Female Graft-versus-host reaction Health aspects Health risk assessment Hematology Hematopoietic Stem Cell Transplantation - methods Humans Immunotherapy Immunotherapy - methods Internal Medicine Lymphocytes T Male Medical research Medicine Medicine & Public Health Mortality Multiple myeloma Multiple Myeloma - drug therapy Multiple Myeloma - pathology Multiple Myeloma - therapy Neoplasm Recurrence, Local Patients Public Health review Risk groups Stem cell transplantation Stem Cells Systematic review Thalidomide Transplantation Transplantation Conditioning - methods Transplantation, Homologous - methods Transplants & implants
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!